Medical Blog About Treatment Abroad

Pancreatic cancer (ICD C25) is one of the most common gastrointestinal cancers. More than 300,000 new cases are diagnosed in the world every year. This tumor accounts for 3% of all cancers, which is a fairly high figure. The treatment methods offered in Germany allow for achieving excellent results, even at stage 4 of the pathology.

Bladder cancer stage 4 is the most advanced form of the disease, characterized by the spread of cancer cells beyond the bladder to distant lymph nodes, the liver and lungs, and even the bones. According to statistics, bladder cancer is among the most common malignancies worldwide, with an estimated 573,000 new cases diagnosed annually and...

Imagine a treatment that boosts your own immune response to fight lung cancer with precision, causing virtually no side effects while you maintain your daily routine. Dendritic cell therapy offers this possibility to patients at any cancer stage, showing effectiveness rates of 50-65% across various cancer types. With lung cancer affecting 226,650 new...

Colorectal cancer (CRC) is a significant public health concern in Germany, ranking among the most commonly diagnosed cancers. In 2022, approximately 24,650 women and 29,960 men were newly diagnosed with CRC. The incidence rates are notably higher in individuals over the age of 55, with the majority of cases originating in the colon...

Esophageal cancer is one of the twenty most widespread cancer types. The disease can develop at any age, but most often it is diagnosed over the age of 60, when treatment options are already somewhat limited by the patient's chronic conditions. Patients who undergo treatment in Germany have a chance to significantly increase...

In recent years, doctors in developed countries have increasingly used immunotherapy treatment for leukemia. Healthcare professionals in Germany use innovative drugs that help cope with even refractory and relapsing forms of leukemia. Immunotherapy is mainly used for acute lymphocytic leukemia.

Dendritic cell prostate cancer treatment represents a groundbreaking immunotherapy approach, recognized by the 2011 Nobel Prize in Physiology or Medicine, awarded to Ralph Steinman. This innovative method can be prescribed to men of all ages and at any stage of prostate cancer, serving as an effective addition to standard treatment....

Thyroid cancer is one of the most rapidly growing endocrine malignancies worldwide. In Europe, the annual incidence reaches 8.3 cases per 100,000 population, while the mortality remains relatively low at 0.33 per 100,000. This situation reflects the effectiveness of modern diagnostic tools and treatment options, as well as the generally...